BLUE STAR FOODS CORP (BSFC)

US09606H3093 - Common Stock

0.2246  -0.03 (-12.61%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to BSFC. BSFC was compared to 90 industry peers in the Food Products industry. BSFC may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, BSFC is valued expensive at the moment.



0

1. Profitability

1.1 Basic Checks

BSFC had negative earnings in the past year.
BSFC had a negative operating cash flow in the past year.
In the past 5 years BSFC always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: BSFC reported negative operating cash flow in multiple years.

1.2 Ratios

The Return On Assets of BSFC (-49.40%) is worse than 86.52% of its industry peers.
BSFC has a worse Return On Equity (-86.75%) than 82.02% of its industry peers.
Industry RankSector Rank
ROA -49.4%
ROE -86.75%
ROIC N/A
ROA(3y)-79.62%
ROA(5y)-65.9%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

BSFC's Gross Margin of 3.90% is on the low side compared to the rest of the industry. BSFC is outperformed by 89.89% of its industry peers.
In the last couple of years the Gross Margin of BSFC has declined.
The Profit Margin and Operating Margin are not available for BSFC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 3.9%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-37.46%
GM growth 5Y-30%

2

2. Health

2.1 Basic Checks

BSFC does not have a ROIC to compare to the WACC, probably because it is not profitable.
BSFC has more shares outstanding than it did 1 year ago.
The number of shares outstanding for BSFC has been increased compared to 5 years ago.
The debt/assets ratio for BSFC has been reduced compared to a year ago.

2.2 Solvency

BSFC has an Altman-Z score of -6.57. This is a bad value and indicates that BSFC is not financially healthy and even has some risk of bankruptcy.
BSFC has a Altman-Z score of -6.57. This is amonst the worse of the industry: BSFC underperforms 89.89% of its industry peers.
A Debt/Equity ratio of 0.22 indicates that BSFC is not too dependend on debt financing.
BSFC has a Debt to Equity ratio of 0.22. This is in the better half of the industry: BSFC outperforms 64.04% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Altman-Z -6.57
ROIC/WACCN/A
WACC18.81%

2.3 Liquidity

BSFC has a Current Ratio of 1.78. This is a normal value and indicates that BSFC is financially healthy and should not expect problems in meeting its short term obligations.
BSFC has a Current ratio (1.78) which is in line with its industry peers.
BSFC has a Quick Ratio of 1.78. This is a bad value and indicates that BSFC is not financially healthy enough and could expect problems in meeting its short term obligations.
BSFC has a Quick ratio (0.97) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.78
Quick Ratio 0.97

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 97.54% over the past year.
The Revenue for BSFC has decreased by -17.80% in the past year. This is quite bad
BSFC shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -28.23% yearly.
EPS 1Y (TTM)97.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%95.04%
Revenue 1Y (TTM)-17.8%
Revenue growth 3Y-24.28%
Revenue growth 5Y-28.23%
Sales Q2Q%7.31%

3.2 Future

The Earnings Per Share is expected to grow by 12.79% on average over the next years. This is quite good.
BSFC is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 42.29% yearly.
EPS Next Y112.5%
EPS Next 2Y32.29%
EPS Next 3Y20.51%
EPS Next 5Y12.79%
Revenue Next Year202.73%
Revenue Next 2Y42.29%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

BSFC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BSFC. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as BSFC's earnings are expected to grow with 20.51% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.29%
EPS Next 3Y20.51%

0

5. Dividend

5.1 Amount

No dividends for BSFC!.
Industry RankSector Rank
Dividend Yield N/A

BLUE STAR FOODS CORP

NASDAQ:BSFC (11/18/2024, 3:35:10 PM)

0.2246

-0.03 (-12.61%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap563.75K
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -49.4%
ROE -86.75%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 3.9%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.82
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.78
Quick Ratio 0.97
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)97.54%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y112.5%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-17.8%
Revenue growth 3Y-24.28%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y